VIKING GLOBAL INVESTORS LPVIKING GLOBAL INVESTORS LP

Institutional investor · Portfolio as of Q2 2019

SEC EDGAR SourceSEC Filings

Top Holdings59 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

Adaptive Biotechnologies Corp.

38.4M$1.9B8.3%$48.300.00%
1 qtr
New
98

AMAZON.COM INC

802,837$1.5B6.8%$86.61+9.32%
3 qtrssince 2018-Q4
Increased
100

ANTHEM INC

5.2M$1.5B6.6%$240.75+7.43%
3 qtrssince 2018-Q4
Decreased
0

META PLATFORMS INC-CLASS A

7.1M$1.4B6.1%$173.76+10.30%
3 qtrssince 2018-Q4
Increased
100

UNITEDHEALTH GROUP INC

4.8M$1.2B5.3%$219.86-0.21%
3 qtrssince 2018-Q4
Increased
78

MICROSOFT CORP

7.7M$1B4.6%$93.93+34.50%
3 qtrssince 2018-Q4
Decreased
0

BOEING CO/THE

2.8M$1B4.5%$357.530.00%
1 qtr
New
88
JDJD
ADR

JD.COM INC-ADR

31.8M$963.9M4.3%$27.44+0.17%
2 qtrssince 2019-Q1
Increased
94
6.7M$878.1M3.9%
3 qtrssince 2018-Q4
Decreased
0

NETFLIX INC

2.1M$759.5M3.4%$25.98+41.39%
3 qtrssince 2018-Q4
Increased
60

CENTENE CORP

14M$733.9M3.3%$52.86-0.80%
3 qtrssince 2018-Q4
Increased
94

BRIDGEBIO PHARMA INC

26.6M$718M3.2%$26.970.00%
1 qtr
New
88

UBER TECHNOLOGIES INC

13.4M$620M2.8%$46.380.00%
1 qtr
New
82

MONSTER BEVERAGE CORP

8.9M$565M2.5%$31.920.00%
1 qtr
New
81

MERCADOLIBRE INC

854,831$523M2.3%$537.30+13.86%
2 qtrssince 2019-Q1
Increased
71

ILLUMINA INC

1.4M$504.8M2.3%$299.81+19.45%
3 qtrssince 2018-Q4
Increased
62

SALESFORCE.COM INC

2.9M$443.4M2.0%$149.910.00%
1 qtr
New
71

LIBERTY

11.4M$425.7M1.9%

BOSTON SCIENTIFIC CORP

9.2M$395.2M1.8%$40.07+7.26%
3 qtrssince 2018-Q4
Increased
79
ATVIATVIDelisted

ACTIVISION BLIZZARD INC

7.9M$373.3M1.7%
2 qtrssince 2019-Q1
Increased
71
$22.3B
AUM
59
Positions
Q2 2019
Filing
Rating · 2.5
Quarterly Portfolio Change
-1%Q1'19$17.4B+28%Q2'19$22.3B
Activity profile
$ moved · Q2'19
New37%Increased26%Decreased22%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 quarters
<1Q29%1-4Q69%1-2Y0%2Y+2%

VIKING GLOBAL INVESTORS LP manages $22.3B across 59 positions as of Q2 2019. Top holdings: ADPT (8.3%), AMZN (6.8%), ELV (6.6%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2.5/5.0.

Q2 2019 Summary

Active quarter - 19 new positions, 17 exits, 16 increased. Top move: AMZN (INCREASED, conviction 100). Portfolio: $22.3B across 59 positions.

Top holdings by portfolio weight

Total AUM$22B
ADPT8.32%
AMZN6.82%
ELV6.58%
META6.12%
UNH5.27%
MSFT4.63%
BA4.54%
JD4.33%
UTX3.94%
NFLX3.41%
Other3.29%

Portfolio allocation by GICS sector

Sectors8
Healthcare36.97%
Consumer Cyclical15.46%
Technology13.90%
Communication Services13.39%
Unknown10.49%
Industrials5.07%
Consumer Defensive2.54%
Financial Services2.19%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Consumer Cyclical, Technology
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record50
Conviction49
Concentration54
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VVVISA INC-CLASS A SHARES
Q3 2025 Q2 2026+4.8M shares+$1.6B
3Q
MAAMAAMID-AMERICA APARTMENT COMM
Q4 2025 Q2 2026+2.4M shares+$331.1M
3Q
SESESEA LTD-ADR
Q4 2025 Q2 2026+2.6M shares+$147,561
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used